# Schneider National, Inc.: financial statements, quarterly

SNDR · NYSE · CIK 1692063 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sndr.md) · [Financials](/companies/sndr/financials.md) · [Filings](/companies/sndr/filings.md) · [Insiders](/companies/sndr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sndr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,372 d](/filings/0001692063-26-000013.md) | [1,319](/filings/0001692063-25-000039.md) | [1,317](/filings/0001692063-25-000054.md) | [1,316](/filings/0001692063-25-000068.md) | [1,339 d](/filings/0001692063-26-000013.md) | [1,402](/filings/0001692063-26-000025.md) | [1,421](/filings/0001692063-26-000039.md) | [1,452](/filings/0001692063-26-000062.md) | [1,400 d](/filings/0001692063-26-000013.md) | [1,399](/filings/0001692063-26-000025.md) | [1,569](/filings/0001692063-26-000039.md) | [1,585](/filings/0001692063-26-000062.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [31.3 d](/filings/0001692063-26-000013.md) | [28.7](/filings/0001692063-25-000039.md) | [51.0](/filings/0001692063-25-000054.md) | [43.1](/filings/0001692063-25-000068.md) | [42.4 d](/filings/0001692063-26-000013.md) | [42.1](/filings/0001692063-26-000025.md) | [55.0](/filings/0001692063-26-000039.md) | [35.3](/filings/0001692063-26-000062.md) | [36.5 d](/filings/0001692063-26-000013.md) | [33.4](/filings/0001692063-26-000025.md) | [71.4](/filings/0001692063-26-000039.md) | [62.1](/filings/0001692063-26-000062.md) |
| Interest expense | $m | [4.1 d](/filings/0001692063-24-000038.md) | [4.0](/filings/0001692063-24-000100.md) | [4.3](/filings/0001692063-24-000121.md) | [3.6](/filings/0001692063-25-000068.md) | [4.7 d](/filings/0001692063-26-000013.md) | [7.8](/filings/0001692063-26-000025.md) | [8.6](/filings/0001692063-26-000039.md) | [9.5](/filings/0001692063-26-000062.md) | [7.9 d](/filings/0001692063-26-000013.md) | [7.0](/filings/0001692063-26-000025.md) | [6.9](/filings/0001692063-26-000039.md) | [(1.9)](/filings/0001692063-26-000062.md) |
| Income tax | $m | [0.1 d](/filings/0001692063-26-000013.md) | [6.2](/filings/0001692063-25-000039.md) | [11.7](/filings/0001692063-25-000054.md) | [8.7](/filings/0001692063-25-000068.md) | [8.6 d](/filings/0001692063-26-000013.md) | [8.7](/filings/0001692063-26-000025.md) | [11.4](/filings/0001692063-26-000039.md) | [7.0](/filings/0001692063-26-000062.md) | [7.3 d](/filings/0001692063-26-000013.md) | [6.8](/filings/0001692063-26-000025.md) | [15.9](/filings/0001692063-26-000039.md) | [16.1](/filings/0001692063-26-000062.md) |
| Net income | $m | [27.4 d](/filings/0001692063-26-000013.md) | [18.5](/filings/0001692063-25-000068.md) | [35.3](/filings/0001692063-25-000068.md) | [30.6](/filings/0001692063-25-000068.md) | [32.6 d](/filings/0001692063-26-000013.md) | [26.1](/filings/0001692063-26-000062.md) | [36.0](/filings/0001692063-26-000062.md) | [19.4](/filings/0001692063-26-000062.md) | [22.1 d](/filings/0001692063-26-000013.md) | [20.4](/filings/0001692063-26-000062.md) | [49.7](/filings/0001692063-26-000062.md) | [49.5](/filings/0001692063-26-000062.md) |
| Diluted EPS | $ per share | not reported | [0.10](/filings/0001692063-25-000039.md) | [0.20](/filings/0001692063-25-000054.md) | [0.17](/filings/0001692063-25-000068.md) | not reported | [0.15](/filings/0001692063-26-000025.md) | [0.20](/filings/0001692063-26-000039.md) | [0.11](/filings/0001692063-26-000062.md) | not reported | [0.12](/filings/0001692063-26-000025.md) | [0.28](/filings/0001692063-26-000039.md) | [0.28](/filings/0001692063-26-000062.md) |
| Basic EPS | $ per share | not reported | [0.11](/filings/0001692063-25-000039.md) | [0.20](/filings/0001692063-25-000054.md) | [0.17](/filings/0001692063-25-000068.md) | not reported | [0.15](/filings/0001692063-26-000025.md) | [0.21](/filings/0001692063-26-000039.md) | [0.11](/filings/0001692063-26-000062.md) | not reported | [0.12](/filings/0001692063-26-000025.md) | [0.28](/filings/0001692063-26-000039.md) | [0.28](/filings/0001692063-26-000062.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [102](/filings/0001692063-24-000136.md) | [67.3](/filings/0001692063-24-000100.md) | [103](/filings/0001692063-24-000121.md) | [179](/filings/0001692063-24-000136.md) | [118](/filings/0001692063-25-000068.md) | [106](/filings/0001692063-25-000039.md) | [161](/filings/0001692063-25-000054.md) | [194](/filings/0001692063-25-000068.md) | [202](/filings/0001692063-26-000062.md) | [228](/filings/0001692063-26-000025.md) | [293](/filings/0001692063-26-000039.md) | [326](/filings/0001692063-26-000062.md) |
| Current assets | $m | [1,111](/filings/0001692063-25-000023.md) | [1,071](/filings/0001692063-24-000100.md) | [1,050](/filings/0001692063-24-000121.md) | [1,088](/filings/0001692063-24-000136.md) | [1,115](/filings/0001692063-26-000013.md) | [1,165](/filings/0001692063-25-000039.md) | [1,165](/filings/0001692063-25-000054.md) | [1,222](/filings/0001692063-25-000068.md) | [1,181](/filings/0001692063-26-000062.md) | [1,328](/filings/0001692063-26-000025.md) | [1,416](/filings/0001692063-26-000039.md) | [1,432](/filings/0001692063-26-000062.md) |
| Total assets | $m | [4,557](/filings/0001692063-25-000023.md) | [4,579](/filings/0001692063-24-000100.md) | [4,548](/filings/0001692063-24-000121.md) | [4,575](/filings/0001692063-24-000136.md) | [4,934](/filings/0001692063-26-000013.md) | [4,979](/filings/0001692063-25-000039.md) | [4,956](/filings/0001692063-25-000054.md) | [4,979](/filings/0001692063-25-000068.md) | [4,840](/filings/0001692063-26-000062.md) | [4,923](/filings/0001692063-26-000025.md) | [4,996](/filings/0001692063-26-000039.md) | [4,998](/filings/0001692063-26-000062.md) |
| Current liabilities | $m | [606](/filings/0001692063-25-000023.md) | [744](/filings/0001692063-24-000100.md) | [659](/filings/0001692063-24-000121.md) | [657](/filings/0001692063-24-000136.md) | [705](/filings/0001692063-26-000013.md) | [614](/filings/0001692063-25-000039.md) | [610](/filings/0001692063-25-000054.md) | [580](/filings/0001692063-25-000068.md) | [556](/filings/0001692063-26-000062.md) | [682](/filings/0001692063-26-000025.md) | [697](/filings/0001692063-26-000039.md) | [694](/filings/0001692063-26-000062.md) |
| Total liabilities | $m | [1,600](/filings/0001692063-25-000023.md) | [1,637](/filings/0001692063-24-000100.md) | [1,596](/filings/0001692063-24-000121.md) | [1,608](/filings/0001692063-24-000136.md) | [1,947](/filings/0001692063-26-000013.md) | [1,990](/filings/0001692063-25-000039.md) | [1,944](/filings/0001692063-25-000054.md) | [1,958](/filings/0001692063-25-000068.md) | [1,815](/filings/0001692063-26-000062.md) | [1,903](/filings/0001692063-26-000025.md) | [1,937](/filings/0001692063-26-000039.md) | [1,901](/filings/0001692063-26-000062.md) |
| Long-term debt | $m | [190](/filings/0001692063-25-000023.md) | not reported | not reported | not reported | [416](/filings/0001692063-26-000013.md) | [562](/filings/0001692063-25-000039.md) | [510](/filings/0001692063-25-000054.md) | [507](/filings/0001692063-25-000068.md) | [388](/filings/0001692063-26-000062.md) | [386](/filings/0001692063-26-000025.md) | [384](/filings/0001692063-26-000039.md) | [380](/filings/0001692063-26-000062.md) |
| Current portion of debt | $m | [100](/filings/0001692063-25-000023.md) | not reported | not reported | not reported | [98.7](/filings/0001692063-26-000013.md) | [7.5](/filings/0001692063-25-000039.md) | [9.9](/filings/0001692063-25-000054.md) | [9.8](/filings/0001692063-25-000068.md) | [8.6](/filings/0001692063-26-000062.md) | [8.5](/filings/0001692063-26-000025.md) | [8.5](/filings/0001692063-26-000039.md) | [10.0](/filings/0001692063-26-000062.md) |
| Shareholders' equity | $m | [2,957](/filings/0001692063-26-000013.md) | [2,942](/filings/0001692063-25-000068.md) | [2,952](/filings/0001692063-25-000068.md) | [2,967](/filings/0001692063-25-000068.md) | [2,987](/filings/0001692063-26-000062.md) | [2,988](/filings/0001692063-26-000062.md) | [3,013](/filings/0001692063-26-000062.md) | [3,021](/filings/0001692063-26-000062.md) | [3,025](/filings/0001692063-26-000062.md) | [3,020](/filings/0001692063-26-000062.md) | [3,059](/filings/0001692063-26-000062.md) | [3,097](/filings/0001692063-26-000062.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [194 d](/filings/0001692063-26-000013.md) | [97.6](/filings/0001692063-25-000039.md) | [183 d](/filings/0001692063-25-000054.md) | [206 d](/filings/0001692063-25-000068.md) | [200 d](/filings/0001692063-26-000013.md) | [91.7](/filings/0001692063-26-000025.md) | [176 d](/filings/0001692063-26-000039.md) | [184 d](/filings/0001692063-26-000062.md) | [186 d](/filings/0001692063-26-000013.md) | [92.9](/filings/0001692063-26-000025.md) | [171 d](/filings/0001692063-26-000039.md) | [139 d](/filings/0001692063-26-000062.md) |
| Capital expenditure | $m | [160 d](/filings/0001692063-26-000013.md) | [123](/filings/0001692063-25-000039.md) | [97.1 d](/filings/0001692063-25-000054.md) | [108 d](/filings/0001692063-25-000068.md) | [85.9 d](/filings/0001692063-26-000013.md) | [114](/filings/0001692063-26-000025.md) | [69.1 d](/filings/0001692063-26-000039.md) | [128 d](/filings/0001692063-26-000062.md) | [40.5 d](/filings/0001692063-26-000013.md) | [40.9](/filings/0001692063-26-000025.md) | [113 d](/filings/0001692063-26-000039.md) | [137 d](/filings/0001692063-26-000062.md) |
| Dividends paid | $m | [15.9 d](/filings/0001692063-26-000013.md) | [16.5](/filings/0001692063-25-000039.md) | [16.8 d](/filings/0001692063-25-000054.md) | [16.6 d](/filings/0001692063-25-000068.md) | [16.7 d](/filings/0001692063-26-000013.md) | [17.0](/filings/0001692063-26-000025.md) | [16.7 d](/filings/0001692063-26-000039.md) | [16.6 d](/filings/0001692063-26-000062.md) | [16.7 d](/filings/0001692063-26-000013.md) | [17.1](/filings/0001692063-26-000025.md) | [17.5 d](/filings/0001692063-26-000039.md) | [17.5 d](/filings/0001692063-26-000062.md) |
| Share repurchases | $m | [15.9 d](/filings/0001692063-26-000013.md) | [13.0](/filings/0001692063-25-000039.md) | [12.8 d](/filings/0001692063-25-000054.md) | [3.7 d](/filings/0001692063-25-000068.md) | [0.0 d](/filings/0001692063-26-000013.md) | [8.3](/filings/0001692063-26-000025.md) | [0.0 d](/filings/0001692063-26-000039.md) | [0.0 d](/filings/0001692063-26-000062.md) | [6.3 d](/filings/0001692063-26-000013.md) | [5.2](/filings/0001692063-26-000025.md) | [0.0 d](/filings/0001692063-26-000039.md) | [0.0 d](/filings/0001692063-26-000062.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [179](/filings/0001692063-24-000100.md) | [179](/filings/0001692063-24-000121.md) | [178](/filings/0001692063-24-000136.md) | [177](/filings/0001692063-25-000039.md) | [176](/filings/0001692063-25-000054.md) | [176](/filings/0001692063-25-000068.md) | [176](/filings/0001692063-26-000025.md) | [176](/filings/0001692063-26-000039.md) | [176](/filings/0001692063-26-000062.md) | [176](/filings/0001692063-26-000025.md) | [176](/filings/0001692063-26-000039.md) | [176](/filings/0001692063-26-000062.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 13:55 ET. No prices; not investment advice.